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ABSTRACT 
 
BACKGROUND: Patients with familial adenomatous polyposis who undergo surgery to 
prevent colorectal cancer experience various abdominal symptoms that may affect their 
physical and mental health. 
OBJECTIVE: This study was designed to investigate self-reported presence, frequency, 
and troublesomeness of abdominal symptoms in such patients in relation to sex, type of 
surgery, and physical and mental health. 
DESIGN: A cohort study with a descriptive and comparative cross-sectional design. 
SETTING AND PARTICIPANTS: All adult patients in the Swedish Polyposis Registry 
(Karolinska University Hospital, Stockholm, Sweden) who were diagnosed with familial 
adenomatous polyposis, had undergone prophylactic colorectal surgery, and were aged 18 
to 75 years were invited to return a mailed questionnaire. 
MAIN OUTCOME MEASURES: Self-reported presence, frequency, and 
troublesomeness of 21 abdominal symptoms were assessed with the Abdominal 
Symptom Questionnaire. Physical health and mental health were evaluated with the 
Medical Outcomes Study Short Form 36 Health Survey. 
RESULTS: Of 275 eligible patients, 209 (76%) responded. Of respondents, 91% 
reported having had at least 1 symptom during the last 3 months. All 21 symptoms 
investigated were reported. A higher number of symptoms was reported by women than 
by men: mean, 7.55 (SD, 4.89) vs 5.14 (4.49); P < .01. No significant difference was 
found between women and men in overall troublesomeness of symptoms: 3.15 (1.30) vs 
3.09 (1.27); P = .763. Self-reported number of symptoms was an independent predictor of 
physical and mental health, with a high number of symptoms related to poor physical and 
mental health. 
LIMITATIONS: The Abdominal Symptom Questionnaire has not been previously used 
in patients with FAP, and measurement of physical and mental health with the Short 
Form 36 Health Survey may not capture all aspects of health status in patients with 
familial adenomatous polyposis. 
CONCLUSION: Patients with familial adenomatous polyposis suffer from a wide 
variety of abdominal symptoms after colorectal surgery. Identification of patients with a 
high number of abdominal symptoms is especially important because the number of 
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abdominal symptoms affects patients’ physical and mental health. 
 
 
KEY WORDS: Familial adenomatous polyposis; Abdominal symptoms; Health status; 
Patient questionnaires; Colorectal surgery. 
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INTRODUCTION 
To prevent colorectal cancer, most patients with familial adenomatous polyposis (FAP) 
undergo one of the following procedures between the ages of 18 and 20 years: removal of 
the colon with construction of an ileorectal anastomosis (IRA) or removal of both the 
colon and rectum with construction of an ileal pouch anal anastomosis (IPAA) or 
ileostomy.1,2 Patients with FAP are normally asymptomatic before surgery, but after 
surgery they report various symptoms, such as an increase in number of bowel 
movements per day, nighttime defecation, leakage, fecal urgency, difficulty in 
distinguishing gas from feces, perianal skin problems, and small-bowel obstruction. Most 
patients also report a need for dietary restrictions3,4 to avoid disturbing abdominal 
symptoms.5 Symptoms have been suggested to be more prevalent in patients with an 
IPAA than in those with an IRA;3 knowledge is limited regarding symptoms experienced 
by patients with an ileostomy.6 As measured with standardized questionnaires, health 
status in patients with FAP after prophylactic colorectal surgery has been reported to be 
equivalent to population norms.4,6-9 
 
To explore patients’ views of what it is like to live with FAP, our research group 
conducted focus-group interviews among patients who had undergone prophylactic 
colorectal surgery.5 The results showed that abdominal discomfort and pain were 
important reasons for concern in regard to living with FAP, including insecurity caused 
by uncertainty about what to eat in order to avoid intestinal problems, as well as a need 
for extensive planning before participating in social activities. Furthermore, many 
patients expressed unmet needs for professional support. 
 
A symptom has been defined as a subjective experience reflecting changes in an 
individual’s biopsychosocial functioning, sensations or cognition—as opposed to a sign, 
which is defined as any abnormality indicative of disease, detectable by the individual or 
by others.10 Because the experience of symptoms is considered to be subjective, the 
patient’s perception of symptoms is crucial for the identification of strategies to alleviate 
or remedy symptoms.11 In the study reported here, we wanted to investigate abdominal 
symptoms from the patient’s perspective. The aim was to investigate self-reporting by 
adults with FAP with regard to presence, frequency, and troublesomeness of abdominal 
symptoms in relation to health status. An additional aim was to study abdominal 
symptoms in relation to sex and type of colorectal surgery performed. 
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MATERIALS AND METHODS 
This cohort study has a descriptive and comparative cross-sectional design. Ethical 
approval was granted by the Regional Ethical Review Board in Stockholm. All patients in 
the national Swedish polyposis registry who were diagnosed with FAP, had undergone 
prophylactic colorectal surgery, and were aged 18 to 75 years were eligible to participate. 
 
Instruments 
Data collection was based on 2 standardized questionnaires: the Abdominal Symptom 
Questionnaire (ASQ)12 for abdominal symptoms, and the Medical Outcomes Study Short 
Form 36 Health Survey (SF-36)13 for health status, including physical and mental health. 
 
The original ASQ was divided into 3 parts. The questionnaire used in this study 
was based on the first part, presenting a list of 21 general abdominal symptoms and 
asking respondents to indicate (by answering yes or no) whether they had been troubled 
by any of these symptoms during the last 3 months. If they answered “yes” they were 
asked to indicate whether the symptom occurred “every day”, “every week”, or “every 
month”. To assess the degree of  “troublesomeness” of symptoms, patients were also 
asked to rate the severity of each symptom on a 7-point Likert-style scale (1 = “mild” and 
7 = “very severe”). The complete ASQ was originally designed to identify 3 functional 
gastrointestinal disorders—dyspepsia, gastroesophageal reflux symptoms, and irritable 
bowel syndrome—and the questionnaire has shown acceptable sensitivity and specificity 
in identifying persons with dyspepsia and irritable bowel syndrome.12 
Five additional abdominal symptoms not included in the ASQ were added to the 
questionnaire for the present study. These items asked the respondents to indicate (by 
answering yes or no) whether they had experienced the following problems: pain when 
eating certain foods, increased bowel movements, daytime leakage, nighttime leakage, 
and perianal soreness. 
 
The SF-3613 consists of 36 items: 35 items measure the following 8 dimensions of 
health status: physical functioning, role-physical (which refers to role limitations due to 
physical difficulties), bodily pain, general health, vitality, social functioning, roleemotional 
(which refers to role limitations due to emotional difficulties), and mental 
health; 1 item assesses perceived differences in health status over the past year. Response 
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choices vary from 2 to 6 possibilities. In addition to the item concerning health transition 
over the past year, 20 items refer to the 4 previous weeks, and 15 items concern the present. 
Raw scores for each item are coded, summed, and transformed into a scale from 
0 (worst possible health status) to 100 (best possible health status), following standard 
SF-36 scoring algorithms.13 Based on the 8 dimensions, 2 summary scales have been 
constructed for physical and mental health: the physical component summary and the 
mental component summary. The physical component summary score is primarily a 
measure of the physical functioning, role-physical, bodily pain, and general health 
dimensions, whereas the mental component summary score mainly encompasses vitality, 
social functioning, role-emotional, and mental health.14 The Swedish version of the SF-36 
has shown satisfactory results regarding reliability and validity.15,16 
 
Demographic and clinical characteristics of all eligible patients were collected from 
the national Swedish Polyposis Registry. 
 
Procedures 
A letter inviting participation in the study was sent to all patients in the Swedish 
Polyposis Registry who fulfilled the eligibility criteria. The letter included information 
about the study and contained the package of questionnaires. The letter stressed that 
participation was voluntary and that nonparticipation would not affect a patient’s care or 
treatment. Patients who were willing to participate were asked to complete the 
questionnaire and return it in an enclosed postage-paid envelope. Patients who did not 
return the questionnaire were sent a reminder after 3 weeks. All returned questionnaires 
were read through to detect missing data, and participants were contacted by phone for 
completion when necessary. 
 
Data Analysis 
Statistical analyses were performed with the Statistical Package for Social Sciences 
(SPSS) for Windows, version 17.0 (SPSS Inc, Chicago, IL). Missing values for the SF-36 
were substituted if half or more of the items within a scale were responded to; that is, a 
person-specific mean score was calculated based on the existing answers. The overall 
troublesomeness of symptoms as measured by the ASQ was calculated by adding up the 
scores (possible score, 1–7) for all symptoms and dividing the sum by the number of 
reported symptoms. 
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Descriptive statistics were computed for scales and standardized questions. 
Independent t tests and 1-way ANOVA were calculated to investigate potential 
differences in mean values between groups (eg, sex, age at time of last colorectal surgery, 
type of surgery). Relationships between variables (number of symptoms, perceived 
troublesomeness of symptoms, age at study entry, age at first and last surgery) were 
studied using Pearson correlation coefficients. Coefficients of 0.29 or less were 
interpreted as low, 0.30 to 0.49 as moderate, and greater than 0.49 as high.17 Two 3-step 
hierarchical multiple regression analyses were performed to determine predictors of the 
physical and mental health component summaries of the SF-36. Variables theoretically 
considered to have an impact on patients’ physical and mental health were entered into 
the model. In the first step, age, sex, and FAP in the family were included. In the second 
step, age at last colorectal surgery and type of performed surgery (IRA, IPAA, or 
ileostomy) were forced into the model, and in the third step, number of symptoms and 
troublesomeness were forced into the model. A statistical significance level of P < .05 
was applied in all analyses. 
 
RESULTS 
A total of 276 patients met eligibility criteria and were invited to participate in the study. 
One patient did not speak Swedish and was therefore excluded. Of the remaining 275 
patients, 209 (76%) consented to participate and were enrolled in the study. 
Demographic and clinical characteristics of the study participants are presented in 
Table 1. The 209 participants represented 111 of 135 known Swedish families with FAP 
(mean number of individuals per family, 1.9; range, 1–22). No statistically significant 
differences in demographic and clinical characteristics were found between participants 
and nonparticipants. Furthermore, no statistically significant differences between men 
and women regarding demographic and clinical characteristics were observed (data not 
shown). Removal of the colon or colorectum (with ileorectal anastomosis, ileal pouch 
anal anastomosis, or ileostomy) had been performed in all but 3 patients, who had 
undergone a segmental resection of the colon, classified as “other” (Table 1). 
 
Presence, Frequency, and Troublesomeness of Symptoms 
Patients’ responses to the ASQ regarding presence, frequency, and troublesomeness of 
abdominal symptoms are shown in Table 2. A total of 190 patients (91%) reported 
having had at least 1 symptom during the past 3 months. All 21 symptoms included in the 
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ASQ were reported, with diarrhea being the most commonly reported symptom overall, 
followed by borborygmi (stomach growling), and nighttime urge of defecation. In 
patients with an IRA, the most prevalent symptom was diarrhea; in patients with an 
IPAA, borborygmi; and in patients with an ileostomy, nighttime urge of defecation (data 
not shown). Although relatively rare (occurring in 13% of patients), constipation was the 
symptom with the highest percentage of patients (86%) reporting daily or at least once 
per week occurrence, closely followed by borborygmi (84%), and belching (84%). 
Interfering flatus had the highest mean value of troublesomeness, closely followed by 
alternating diarrhea and constipation and abdominal discomfort or pain at defecation. 
Presence and troublesomeness of abdominal symptoms are analyzed according to 
sex and type of prophylactic procedure in Table 3. Women reported a significantly higher 
number of symptoms compared with men. No significant differences in number of 
symptoms were found when the types of prophylactic colorectal surgery were compared. 
The overall mean score for troublesomeness of abdominal symptoms in our patients was 
3.12 (SD, 1.29; range, 1.06.6). No statistically significant differences were found between 
men and women or among different types of prophylactic procedures in degree of 
reported troublesomeness of symptoms. Perceived troublesomeness correlated 
moderately with the number of reported symptoms (r = 0.44). 
 
Regarding the 5 additional abdominal symptoms included in the questionnaire, 167 
patients (80%) reported having increased bowel movements, 136 patients (65%) reported 
pain when eating certain food, 84 patients (40 %) reported perianal soreness, 61 patients 
(29%) reported daytime leakage, and 82 patients (39%) reported nighttime leakage. 
 
Physical and Mental Health 
Hierarchical multiple regression analyses showed similar predictors for self-reported 
physical health and mental health as assessed with the SF-36 (Table 4). In the first step, 
physical health was significantly predicted by the variables sex and age, whereas mental 
health was significantly predicted by age and presence of FAP in the family. Physical 
health declined with increasing age, while mental health remained stable or improved. 
The second step investigated the impact of time since last colorectal surgery and type of 
colorectal surgery (IRA, IPAA, or ileostomy). These variables had only a negligible 
effect on physical and mental health when the effects of sex, age, and FAP in the family 
were already accounted for. In the third step, the addition of number of symptoms and 
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troublesomeness showed that number of symptoms had the largest impact on physical 
and mental health in the model. When the variances of the other independent factors were 
held constant, only number of self-reported symptoms and age were significant 
contributors to the model. Finally, the independent variables accounted for 33% of the 
variance of the dependent variables physical and mental health scores. 
 
DISCUSSION 
The results of our study showed that patients with FAP experience a large number of 
abdominal symptoms after prophylactic colorectal surgery regardless of the type of 
procedure performed, with a significantly higher number of symptoms reported by 
women than by men. Moreover, the number of self-reported symptoms was the strongest 
predictor of patients’ physical and mental health. As expected, symptoms such as diarrhea, 
nighttime urge of defecation, and flatus, which were previously reported in patients with FAP 
after prophylactic colorectal surgery,3 were frequently reported by patients in the current 
study. However, symptoms not previously reported, such as borborygmi, abdominal 
distension, abdominal discomfort or pain relieved by defecation, and belching, were reported 
by 30% to 62% of our patients. Although such symptoms have been spontaneously 
communicated by patients at our clinic, the number of patients reporting them in this study 
was surprisingly high. In comparison, Agréus et al18 found that corresponding symptoms 
were reported by 4% to 23% of individuals in a general Swedish population.18 
Diarrhea, borborygmi, nighttime urge of defecation, and abdominal distension were 
the most prevalent and most frequently occurring symptoms in our patients, although 
they were not considered the most troublesome. Perceived troublesomeness seems to be 
independent of prevalence and frequency in the present study. Also, perceived 
troublesomeness was only moderately related to number of symptoms, indicating that 
higher numbers of symptoms do not necessarily mean a greater degree of 
troublesomeness. 
 
To our knowledge, only 1 study has investigated bowel function in patients with 
FAP and ileostomy,6 reporting excellent bowel function. In the present study, however, 
patients with an ileostomy did not differ from those with an IRA or IPAA in number or 
troublesomeness of symptoms. This subgroup of patients should be further studied, 
preferably in a multicenter collaboration to gain a sufficient sample size. Nevertheless, 
the findings of the current study should be taken into consideration in the care of patients 
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with an ileostomy: Such patients may need symptom management to the same extent as 
patients with an IRA or IPAA but may not have the same access to health care because 
they have no or less frequent endoscopic surveillance of the stoma and neoterminal 
ileum. 
 
In contrast to other reports,3,7 the present study found no significant differences in 
number of symptoms when patients with different types of surgery are compared. A 
possible explanation for the disparities in results is that the abdominal symptoms assessed 
in the current study are not exclusively related to bowel dysfunction. Nonspecific 
abdominal symptoms may be less dependent on the type of colorectal surgery performed. 
Another explanation could be that the results of this study are based on self-reported data 
reflecting patients’ subjective perception of abdominal symptoms, which may contrast 
with health professionals’ evaluation of patients’ symptoms. Furthermore, surgical 
complications and comorbidity were not investigated in the current study, although 
previous reports show that these variables can affect bowel function.19 
 
To our knowledge, this is the first study comparing men and women with FAP after 
prophylactic colorectal surgery with respect to number of symptoms. As in the general 
population,18 in patients with FAP a significantly higher number of symptoms was 
reported by women than by men. Attempts have been made to explain why women report 
symptoms and health complaints to a greater extent than men do. It has been suggested 
that women have a greater willingness than men to report symptoms they perceive.20 
However, the difference between healthy men and women regarding bowel symptoms 
may at least to some extent be explained by more frequent colonic dysfunction in 
women.21 The fact that these differences remain after colon removal suggests that the 
influence of the colon may be overestimated and that other, not yet fully understood 
mechanisms are important. 
 
In line with reports from Swedish population norms,16 age was a significant 
predictor of physical and mental health in the current study, although the multiple 
regression analyses revealed that number of symptoms had the greatest impact on 
patient’s physical and mental health. Contrary to expectation, troublesomeness of 
symptoms was not a significant predictor of physical and mental health. Future studies of 
symptom perception should assess the different ways that specific symptoms influence 
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daily life. The regression models used in this study explained more than 30% of the 
variance of physical and mental health, suggesting that efforts to alleviate or remedy 
abdominal symptoms can be important in improving overall physical and mental health in 
patients with FAP who undergo colorectal surgery. 
 
The study had a number of specific strengths. First, the combination of a high 
response rate and a large number of patients with IRA, IPAA, or ileostomy resulted in a 
large cohort of patients in which abdominal symptoms could be investigated. Second, 
measuring a broad array of abdominal symptoms—not only the symptoms usually 
assessed in such patients—turned out to be relevant because symptoms such as 
borborygmi and abdominal distension were frequently reported by our patients, 
indicating their importance in this context. Third, the sample size allowed for multivariate 
analysis, making it possible to investigate the influence of several factors at the same 
time. 
 
Some limitations of the study should also be noted. First, the ASQ was originally 
developed to diagnose patients with functional gastrointestinal disorders12 and has not been 
previously used in patients with FAP. Second, measurement of physical and mental 
health using the standardized instrument SF-36 may not capture all aspects of health 
status in patients with FAP.4,19 
 
CONCLUSIONS 
The results of the current study show that patients with FAP suffer from a wide 
variety of abdominal symptoms, independent of type of prophylactic colorectal surgery 
performed. It is therefore crucial to base symptom management on a systematic inventory 
of patients’ perception of symptoms, rather than asking for symptoms generally accepted 
as being related to bowel dysfunction in patients with FAP after colorectal surgery. 
Symptoms such as, interfering flatus, borborygmi and abdominal distension can be 
alleviated with pharmacological treatment and dietary restrictions. Identification of 
patients with a high number of abdominal symptoms is especially important because the 
number of abdominal symptoms was found to influence patients’ physical and mental 
health. Furthermore, symptom management needs to be followed up by specialist 
physicians or specialist nurses familiar with FAP. Future studies should analyze patients’ 
views regarding specific symptoms, how troublesome they are perceived to be, and their 
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impact on patients’ lives, as well as their relation to quality of care. Because abdominal 
symptoms are perceived individually, a qualitative approach may be useful for the 
purpose. 
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Table 1. Clinical characteristics of patients (n=209) 
 mean  
(SD; range) 
n % 
Age 49 (14; 18-75)   
Sex    
 Men 48 (15; 18-75)   93 44 
 Women 49 (13; 23-74) 116 56 
Living situation    
 Partnered  139 67 
 Single     61 29 
 Living with parents or other      9   4 
Occupation    
 Working  123 59 
 Student    12   8 
 Retired    42 20 
 Disability pension    17   8 
 Sick-listed    11   5 
Participants having children  144 69 
FAP in the familya  169 81 
    
Age at diagnosis 26 (12; 3-57)   
Age at first colorectal surgery, years 28 (11; 5-58)   
Time since first colorectal surgery to study, years 21 (12; 1-50)   
Times since last colorectal surgery to study, years 14 (10; 1-50)   
    
Last colorectal surgery     
 IRAb    71 34 
 IPAAc    82 39 
 Ileostomy    39 19 
 Continent ileostomy    14   7 
 Other      3   1 
Total number of colorectal procedures   
 One   132 63 
 Two    66 32 
 Three or more    11   5 
Upper gastrointestinal surgery    23 11 
Desmoid tumor    20 10 
FAP related cancer    50 24 
aHaving family members with FAP 
bIRA=ileorectal anastomisis 
cIPAA=ileal pouch anal anastomosis 
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Table 2. Self-reported symptoms, prevalence, symptoms frequent every day or week the three preceding 
months and troublesomeness, as measured with the Abdominal Symptom Questionnaire 
 Prevalence  
(n=209) 
 
% 
Symptom 
present every 
day or week  
% 
Troublesomenessa 
 
 
mean     (range) 
Diarrhea 67 73 3.81  (1-7) 
Borborygmi 62 84 3.46  (1-7) 
Nighttime urge of defecation 60 80 3.34  (1-7) 
Abdominal distension 50 77 3.58  (1-7) 
Abdominal discomfort or pain relieved by defecation 42 58 3.38  (1-7) 
Interfering flatus 34 82 4.01  (1-7) 
Feelings of incomplete defecation 33 81 3.6  (1-7) 
Uncomfortable feeling of fullness after meals 33 65 3.63  (1-7) 
Nausea 32 52 3.42  (1-7) 
Retrosternal pain 32 43 3.34  (1-7) 
Belching 31 84 2.69  (1-7) 
Heartburn 29 59 3.36  (1-7) 
Early satiety 28 78 3.36  (1-6) 
Abdominal discomfort or pain at defecation 28 67 3.9  (1-7) 
Reflux episodes 23 65 3.43  (1-6) 
Loss of appetite 19 58 3.53  (1-6) 
Constipation 13 86 3.75  (1-7) 
Altering diarrhea and constipation 10 60 4  (2-7) 
Vomiting   9 42 3.84  (1-7) 
Loss of weight   8 NAb NAb 
Dysphagia   6 54 3.38  (1-6) 
Missing data: prevalence n=2, frequency n=14 
a
 possible score 1-7 
bNA=not applicable 
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Table 3. Differences in self-reported symptoms, number and  troublesomeness of symptoms, as 
measured with the Abdominal Symptom Questionnaire (n=209) 
 Number of  
symptomsa  
 Symptom  
troublesomenessb 
 
 Mean SD Range  Mean SD Range  
Males 5.14 4.49 0-18 3.09 1.27 1.0-6.6 
Females 7.55 4.89  0-18 3.15 1.30 1.0-6.2 
       
IRAe 6.51 5.04 0-17 3.09 1.28 1.0-6.6 
IPAAf 7.07 4.84 0-18 3.10 1.27 1.0-6.2 
Ileostomy 5.56 4.41 0-14 3.12 1.38 1.0-6.0 
       
apossible number of symptoms=21  
bpossible range 1-7 
Tested for differences by t-testc  and ANOVA (n=192)d 
eIRA=ileorectal anastomosis, fIPAA=ileal pouch anal anastomosis 
p<0.001c 
p=0.276d 
p=0.763c 
p=0.994d 
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Table 4. Hierarchical multiple linear regression analyses with PCSa and MCSb as the dependent variables (participants=183) 
  PCS MCS 
  β 
standardized 
R2 
change 
R2 
adjusted 
F β 
standardized 
R2 
change 
R2 
adjusted 
F 
 Step 1    0.131* 0.117    9.018*  0.127* 0.112    8.641* 
 Genderc -0.191*    -0.088    
 Age -0.295*       0.287*    
 FAP in the family -0.106    -0.205*    
Step 2   0.017 0.114    4.339*  0.010 0.102    3.957*   
 Gender -0.201*    -0.092    
 Age -0.270*      0.280*    
 FAP in the family -0.096    -0.205*    
 Time since last surgery   0.000    -0.015    
 IRA -0.061        0.034    
 IPAA   0.061      0.140    
 Ileostomy   0.079      0.049    
Step 3   0.217* 0.332 11.043*  0.226* 0.329 10.923* 
 Gender -0.078      0.031    
 Age -0.332*      0.215*    
 FAP in the family   0.002    -0.103    
 Time since last surgery   0.051      0.038    
 IRA -0.111    -0.012    
 IPAA -0.007      0.075    
 Ileostomy   0.066      0.037    
 Number of symptoms -0.465*    -0.459*    
 Troublesomeness  -0.066    -0.093    
*p<0.01 
aPCS=physical component summary score, bMCS=mental component summary score (measured with the SF-36). The scores for PCS and 
MCS range from 0 to 100 with higher scores indicating better health status. 
cMen=1, Women=2 
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